Childhood obesity has tripled in the past 30 years, leading to many chronic lifelong conditions. Obese children, for example, are more likely to have risk factors for cardiovascular disease, are at greater risk for bone and joint problems, and are more likely to become overweight as adults.
Childhood obesity has tripled in the past 30 years, leading to many chronic lifelong conditions. Obese children, for example, are more likely to have risk factors for cardiovascular disease, are at greater risk for bone and joint problems, and are more likely to become overweight as adults.
The Blue Cross and Blue Shield Association (BCBSA) has developed a set of federal policy recommendations aimed at helping prevent childhood obesity. The recommendations focus on four key areas:
1. Promoting physical activity, nutrition and wellness in schools.
2. Empowering parents and families to take steps toward a healthier lifestyle.
3. Coordinating government and private resources.
4. Focusing on underserved and diverse communities, which have been disproportionally affected.
"As community-based health plans with nearly 80 years of experience in providing healthcare benefits, Blue Cross and Blue Shield companies have long pioneered innovative programs in their communities to help address childhood obesity," said Scott P. Serota, BCBSA president and CEO, in a statement. "Blue Cross and Blue Shield companies look forward to working with Congress, the administration and all stakeholders to implement these policies and help create a healthier generation of Americans."
Some of the key recommendations include:
BCBSA collaborated with Blue Cross and Blue Shield companies to develop the recommendations, in addition to looking for opportunities to leverage existing programs and initiatives already underway by the federal government and the private sector.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen